Table 2.
LOBAR ICH (n = 409)
| |||||
---|---|---|---|---|---|
Univariate | Multivariate | ||||
Variable | Coeff (SE) | p-value | Variable | Coeff (SE) | p-value |
Age | 0·024 (0·024) | 0·33 | Age | 0·024 (0·022) | 0·29 |
Sex | −0·267 (0·149) | 0·073 | Sex | −0·049 (0·045) | 0·28 |
HTN | 0·047 (0·160) | 0·77 | HTN | 0·670 (0·731) | 0·36 |
Warfarin Use | 0·040 (0·184) | 0·83 | Warfarin Use | 0·512 (1·379) | 0·71 |
Aspirin Use | −0·172 (0·154) | 0·26 | Aspirin Use | −0·178 (0·719) | 0·80 |
APOE ε2 | 0·471 (0·103) | 1.4 × 10−5 | APOE ε2 | 0·455 (0·108) | 2·5 × 10−5 |
APOE ε4 | 0·083 (0·134) | 0·54 | APOE ε4 | 0·205 (0·131) | 0·12 |
DEEP ICH (n = 456)
| |||||
---|---|---|---|---|---|
Univariate | Multivariate | ||||
Variable | Coeff (SE) | p-value | Variable | Coeff (SE) | p-value |
Age | 0·005 (0·005) | 0·92 | Age | 0·005 (0·006) | 0·93 |
Sex | −0·11 (0·15) | 0·45 | Sex | −0·11 (0·16) | 0·47 |
HTN | −0·12 (0·20) | 0·54 | HTN | −0·15 (0·20) | 0·46 |
Warfarin Use | 0·071 (0·18) | 0·71 | Warfarin Use | 0·08 (0·19) | 0·67 |
Aspirin Use | 0·072 (0·15) | 0·64 | Aspirin Use | 0·085 (0·15) | 0·58 |
APOE ε2 | 0·144 (0·186) | 0·44 | APOE ε2 | 0·130 (0·181) | 0·48 |
APOE ε4 | 0·065 (0·140) | 0·81 | APOE ε4 | 0·070 (0·135) | 0·62 |
Both univariate and multivariate analysis are adjusted for Principal Components 1 and 2 to eliminate possible confounding due to population stratification.
Coeff = Regression Cefficient, HTN = History of Hypertension, SE = Standard Error